Analysis of genotyping for predicting liver injury marker, procollagen III in persons at risk of non-alcoholic fatty liver disease.
Jane I GrovePrarthana ThiagarajanStuart AstburyRebecca HarrisToby DelahookeIndra Neil GuhaGuruprasad Padur AithalPublished in: Liver international : official journal of the International Association for the Study of the Liver (2018)
Genotyping, therefore, has limited value for predicting severe liver disease in at-risk individuals identified in a community setting.